Journal article
The role of CD27 in anti-viral T-cell immunity
EJ Grant, S Nüssing, S Sant, EB Clemens, K Kedzierska
Current Opinion in Virology | ELSEVIER SCI LTD | Published : 2017
Abstract
CD27 is a co-stimulatory immune-checkpoint receptor, constitutively expressed on a broad range of T-cells (αβ and γδ), NK-cells and B-cells. Ligation of CD27 with CD70 results in potent co-stimulatory effects. In mice, co-stimulation of CD8+ T-cells through CD27 promotes immune activation and enhances primary, secondary, memory and recall responses towards viral infections. Limited in vitro human studies support mouse experiments and show that CD27 co-stimulation enhances antiviral T-cell immunity. Given the potent co-stimulatory effects of CD27, manipulating CD27 signalling is of interest for viral, autoimmune and anti-tumour immunotherapies. This review focuses on the role of CD27 co-stimu..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by Australian National Health and Medical Research Council (NHMRC) Program (AI1071916) Grant to KK. EJG is a NHMRC CJ Martin Fellow, EBD is a NHMRC Peter Doherty Fellow and KK is an NHMRC SRF Level B. SN was supported by a Melbourne International Fee Remission Scholarship (MIFRS) and Melbourne International Research Scholarship (MIRS). SS was supported by a Victoria India Doctoral Scholarship (VIDS) and MIFRS.